|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2878 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/21 | (2013.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/75 | (2013.01) | ||
| A61K2039/505 | (2013.01) | ||
| A61P 35/00 | (2018.01) |
| (11) | Number of the document | 3768711 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19714024.7 |
| Date of filing the European patent application | 2019-03-15 | |
| (97) | Date of publication of the European application | 2021-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2023-05-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/022391 |
| Date | 2019-03-15 |
| (87) | Number | WO 2019/182878 |
| Date | 2019-09-26 |
| (30) | Number | Date | Country code |
| 201862647016 P | 2018-03-23 | US |
| (72) |
CARPENITO, Carmine , US
LI, Yiwen , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (54) | ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES |
| ANTI-CD137 ANTIBODIES FOR COMBINATION WITH ANTI-PD-L1 ANTIBODIES |